Literature DB >> 2030816

Chemotherapy in non-Hodgkin's lymphoma during pregnancy.

J Lambert1, P W Wijermans, G A Dekker, G J Ossenkoppele.   

Abstract

A 30-yr-old woman is described with an intermediate-grade non-Hodgkin's lymphoma, localized in the mediastinum, diagnosed in the 22nd week of gestation. Combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, prednisone, teniposide and bleomycin was instituted in the second and third trimesters, resulting in regression of the tumour. Foetal distress due to pre-eclampsia forced us to perform a Caesarean section at 31 weeks of pregnancy. A healthy boy was born without congenital abnormalities. Further chemotherapeutic treatment, combined with radiotherapy, led to a complete remission of the non-Hodgkin's lymphoma; the remission lasted for 6 months. A review of the literature on chemotherapeutic treatment in non-Hodgkin's lymphoma during gestation is provided. Despite the limited number of cases reported, it can be concluded that chemotherapy in non-Hodgkin's lymphoma during pregnancy is less harmful than might be thought.

Entities:  

Mesh:

Year:  1991        PMID: 2030816

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  4 in total

Review 1.  T cell non-Hodgkin's lymphoma presenting in the first trimester of pregnancy.

Authors:  C C Lees; M Tsirigotis; J V Carr; M A Richards
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

2.  Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia--neonatal and infantile course.

Authors:  A Artlich; J Möller; A Tschakaloff; E Schwinger; K Kruse; L Gortner
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

3.  Pharmacokinetics of doxorubicin in pregnant women.

Authors:  Rachel J Ryu; Sara Eyal; Henry G Kaplan; Arezoo Akbarzadeh; Karen Hays; Kristin Puhl; Thomas R Easterling; Stacey L Berg; Kathleen A Scorsone; Eric M Feldman; Jason G Umans; Menachem Miodovnik; Mary F Hebert
Journal:  Cancer Chemother Pharmacol       Date:  2014-02-15       Impact factor: 3.333

Review 4.  The treatment of hematologic malignancies in pregnancy.

Authors:  C Vandenbriele; D Dierickx; F Amant; M Delforge
Journal:  Facts Views Vis Obgyn       Date:  2010
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.